A CD14 promoter polymorphism is associated with CD14 expression and Chlamydia-stimulated TNFα production

Genes and Immunity

Volumn 5, Issue 5, 2004, Pages 426-430

  Eng, H L ^a   Wang, C H ^b   Chen, C H ^b   Chou, M H ^b   Cheng, C T ^b   Lin, T M ^b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

CD14 polymorphism; Chlamydia; LPS; TNF

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CD14 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CHINESE; CHLAMYDIA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; IMMUNITY; INFLAMMATION; MACROPHAGE; MALE; MOLECULAR RECOGNITION; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; PROMOTER REGION; TAIWAN; WESTERN HEMISPHERE;

ADULT; ANTIGENS, CD14; CHLAMYDIA; CHLAMYDIA INFECTIONS; FEMALE; GENE EXPRESSION; HUMANS; MALE; MIDDLE AGED; MONOCYTES; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); TAIWAN; TUMOR NECROSIS FACTOR-ALPHA;

BACTERIA (MICROORGANISMS); CHLAMYDIA; CHLAMYDIAE;

EID: 4344594387     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6364100     Document Type: Article

References (28)

1. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990; 249: 1431-1433.
2. Bazil V, Baudys M, Hilgert I et al. Structural relationship between the soluble and membrane-bound forms of human monocyte surface glycoprotein CD14. Mol Immunol 1989; 26: 657-662.
3. Durieux JJ, Vita N, Popescu O et al. The two soluble forms of the lipopolysaccharide receptor, CD14: characterization and release by normal human momocyte. Eur J Immunol 1994; 24: 2006-2012.
4. da Silva Correia J, Soldau K, Christen U, Tobias PS, Ulevitch RJ. Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex: transfer from CD14 to TLR4 and MD-2. J Biol Chem 2001; 276: 21129-21135.
5. Wright SD. CD14 and innate recognition of bacteria. J Immunol 1995; 155: 6-8.
6. Ulevitch RJ, Tobias PS. Recognition of Gram-negative bacteria and endotoxin by the innate immune system. Curr Opin Immunol 1999; 11: 19-22.
7. LeVan TD, Bloom JW, Bailey TJ et al. A common single nucleotide polymorphism in the CD14 promoter decreases the affinity of Sp protein binding and enhance transcriptional activity. J Immunol 2001; 167: 5838-5844.
8. Hubacek JA, Rothe G, Pit'ha J et al. C(-260)→T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. Circulation 1999; 99: 3218-3220.
9. Unkelbach K, Gardemann A, Kostrzewa M et al. A new promoter polymorphism in the gene of lipopolysaccharide receptor CD14 is associated with expired myocardial infarction in patients with low atherosclerotic risk profile. Arterioscler Thromb Vasc Biol 1999; 19: 932-938.
10. Eng HL, Chen CH, Kuo CC, Wu JS, Wang CH, Lin TM. Association of CD14 gene promotor polymorphism and Chlamydia pneumoniae infection. J Infect Dis 2003; 188: 90-97.
11. Bauriedel G, Welsch U, Likungu JA, Welz A, Luderitz B. Chlamydia pneumoniae in coronary plaques: increased detection with acute coronary syndrome. Dtsch Med Wochensch 1999; 124: 375-380.
12. Rothermel CD, Schachter J, Lavrich P, Lipsitz EC, Francus T. Chlamydia trachomatis-induced production of interleukin-1 by human monocytes. Infect Immun 1989; 57: 2705-2711.
13. Williams DM, Magee DM, Bonewald L et al. A role in vivo for tumor necrosis factor alpha in host defense against Chlamydia trachomatis. Infect Immun 1990; 58: 1572-1576.
14. Louis E, Franchimont D, Piron A et al. Tumor necrosis factor (TNF) gene polymorphism influences TNF-α production in lipopolysaccharide (LPS)-stimulated whole blood culture in health human. Clin Exp Immunol 1998; 113: 401-406.
15. Zee RY, Lindpaintner K, Struk B, Hennekens CH, Ridker PM. A prospective evaluation of CD14(-260) T gene polymorphism and the risk of myocardial infarction. Atherosclerosis 2001; 154: 699-702.
16. Karhukorpi J, Yan Y, Niemela S et al. Effect of CD14 promoter polymorphism and H pylori infection and its clinical outcomes on clinical CD14. Clin Exp Immunol 2002; 128: 326-332.
17. Baldini M, Lohman IC, Halonen M et al. A polymorphism in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol 1999; 20: 976-983.
18. Ito D, Murata M, Tanahashi N et al. Polymorphism in the promoter of lipopolysaccharide receptor CD14 and ischemic cerebrovascular disease. Stroke 2000; 31: 2661-2664.
19. Heesen M, Blomeke B, Schluter B, Heussen N, Rossaint R, Kunz D. Lack of association between the -260C→T promoter polymorphism of the endotoxin receptor CD14 gene and the CD14 density of unstimulated human monocytes and soluble CD14 plasma levels. Intensive Care Med 2001; 27: 1770-1775.
20. Temple SE, Cheong KY, Almeida CM, Price P, Waterer GW. Polymorphisms in lymphotoxin alpha and CD14 influence TNFα production induced by Gram-positive and Gram-negative bacteria. Gene Immun 2003; 4: 283-288.
21. Van der Linden MW, Huizinga TW, Stoeken DJ, Sturk A, Westendorp RG. Determination of tumor necrosis factor-alpha and interleukin-10 production in a whole blood stimulation system: assessment of laboratory error and individual variation. J Immunol Methods 1998; 218: 63-71.
22. Jones J, Schachter MJ, Stephens RS. Evaluation of the humoral immune response in trachoma to Chlamydia trachomatis major outer membrane proteins by sequence-defined immunoassay. J Infect Dis 1992; 166: 915-919.
23. Brade L, Brunnemann H, Ernst M et al. Occurrence of antibodies against chlamydial lipopolysaccharide in human sera measured by ELISA using an artificial glycoconjugated antigen, FEMS. Immunol Med Microbiol 1994; 8: 27-42.
24. Morrison RP, Su H, Lyng K, Yuan Y. The Chlamydia trachomatis hyp operon is homologous to the groE stress response operon of Escherichia coli. Infect Immun 1990; 58: 2701-2705.
25. Netea MG, Selzman CH, Kullberg BJ et al. Acellar components of Chlamydia pneumoniae stimulate cytokine production in human blood mononuclear cells. Eur J Immunol 2000; 30: 541-549.
26. LaVerda D, Kalayoglu MV, Byme GI. Chlamydial heat shock proteins and disease pathology: new paradigms for old problems? Infect Dis Obstet Gynecol 1999; 7: 64-71.
27. Kol A, Lichtman AH, Finberg RW, Libby P, Kurt-Jones EA. Heat shock protein (HSP)60 activates the innate immune response:CD14 is an essential receptor for HSP60 activation of mononuclear cells. J Immun 2000; 164: 13-17.
28. Bulut Y, Faure E, Thomas L et al. Chlamydial heat shock protein 60 activates macrophages and endothelial cells through Toll-like receptor 4 and MD2 in MyD88-dependent pathway. J Immunol 2002; 168: 1435-1440.